Lifetech Scientific Corporation is a developer, manufacturer, and marketer of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases. The company operates three main business segments: structural heart diseases, which includes congenital heart disease occluders and left atrial appendage occluders; peripheral vascular diseases, featuring vena cava filters and stent grafts; and cardiac pacing and electrophysiology, primarily involving pacemakers. The group serves a global market with distributors in Asia, Europe, North America, South America, and Africa, with mainland China remaining its largest revenue source. It maintains an academic exchange platform known as the Lifetech Knowledge Exchange Program, initiated in 2012, to connect cardiovascular experts worldwide. The company holds redeemable shares in Biotyx Medical, a subsidiary referenced in its financial performance discussions.

Summarised from the company's own disclosures, fiscal year ended Apr 2025

Industry Medical Devices Homepage lifetechmed.com
Sector Healthcare IR page lifetechmed.com/investor
Tags
cardiovascular devices, peripheral vascular devices, structural heart, left atrial appendage occlusion, vena cava filters, stent grafts, pacemakers, electrophysiology, minimally invasive surgery, Biotyx Medical, Lifetech Knowledge Exchange Program
Press page —

Metrics

Valuation  
Market cap HK$ 6.5B
Market cap (USD) $ 828.37M
P/E 37.07
PEG —
P/BV 1.69
P/S 4.27
P/OCF 10.76
P/FCF —
Dividend yield —
Turnover / mcap 0.32%
Returns  
ROE 4.3%
ROI 4.3%
ROIC 5.3%
Profit margin 10.8%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) -23.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 0.15%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Revenue 1.37B 1.304B 1.267B 1.097B 925.334M 642.299M 668.879M 556.698M 409.125M 352.849M 311.606M 282.679M 231.035M 181.475M
Net profit 147.827M 222.388M 263.242M 325.337M 292.472M 216.085M 129.2M 121.082M 163.472M 145.652M 2.359M -81.244M -65.666M 32.352M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Share price 1.69 1.29 2.58 2.43 3.87 3.65 1.11 1.17 1.62 — — — — —
Price performance 12m 0.35 -0.5 0 -0.4 0.14 2.3 -0.08 -0.29 — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Lifetech Scientific Corporation (ticker 1302), listed in Hong Kong.

ETFs Holding Lifetech Scientific Corporation

ETF Weight in ETF Shares Market value As of
AVEE 0.09% 640,000 $ 116.526K Nov 16, 2026
AVES 0.05% 4,306,000 $ 784.002K Nov 16, 2026
DFSE 0.01% 328,000 $ 63.554K Nov 12, 2026
AVEM 0.01% 12,008,000 $ 2.186M Nov 16, 2026
DFEM 0.01% 3,692,000 $ 715.372K Nov 12, 2026
DFAE 0.01% 2,616,000 $ 506.883K Nov 12, 2026
DFEV 0.00% 348,000 $ 67.429K Nov 12, 2026
DFAX 0.00% 1,534,000 $ 297.232K Nov 12, 2026